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A 57-year-old Hispanic woman with a history of primary
biliary cirrhosis and CREST syndrome presented with chief
complaint of severe pain in the fingers and toes, progressively
worsening for the past 3 months. Home medications
included calcium and ergocalciferol. Review of systems was
remarkable for right shoulder pain, as well as a 2-week
history of black fingertip on the left second digit. Physical
examination revealed no fever; the blood pressure was
155/80mm/Hg, heart rate was 80 beats per minute, and
respiratory rate was 18 breaths per minute. In addition, she
had dry gangrene of the left second fingertip, and all distal
digits were erythematous and cool to touch.
She was treated with an anticoagulant and a calcium-
channel blocker. Hospital treatment was complicated by
positive blood cultures showing the growth of Haemophilus
influenzae, which was treated with intravenous anti-
biotics. Laboratory results are displayed in Table 1. Owing
to a metabolic abnormality, which persisted across multiple
repeated samples over days, a nephrology consult was
requested.
What is the cause of hyperbicarbonatemia in this patient?
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Table 1 | Patient laboratory results and reference range
Laboratory test Result Reference range
Leukocytes ( 109/l) 7.8 3.8–10.5
Hemoglobin (g/dl) 11.3 11.5–15.5
Erythrocyte volume (fl) 93 80–100
Platelets ( 109/l) 258 150–400
Sodium (mmol/l) 136 132–145
Potassium (mmol/l) 4.1 3.5–5.1
Chloride (mmol/l) 105 96–108
Carbon dioxide (mmol/l) 44 22–31
Blood urea nitrogen (mg/dl) 7 7–23
Creatinine (mg/dl) 0.47 0.5–1.3
Calcium (mg/dl) 8.8 8.4–10.5
Phosphorus (mg/dl) 3.5 2.5–4.5
Erythrocyte sedimentation rate (mm/h) 23 0–20
Albumin (g/dl) 3.1 3.3–5
PT (s) 9.7 10–13.4
PTT (s) 31 27–37.4
INR (ratio) 0.83 88–1.15
IgA (mg/dl) 216 68–378
IgG (mg/dl) 182 694–1618
IgM (mg/dl) 1370 40–230
Serum triglycerides (mg/dl) 80 25–149
Serum cholesterol (mg/dl) 260 90–199
Serum HDL (mg/dl) 83 40–125
Serum LDL (mg/dl) 161 60–99
Thyroid stimulating hormone (mIU/ml) 4.49 0.27–4.2
Complement C3 (mg/dl) 120 80–180
Complement C4 (mg/dl) 13 10–45
RF (IU/ml) 4650 0–13.9
ANA (titer) 1:160 o1:40
Abbreviations: ANA, anti-nuclear antibody; HDL, high-density lipoprotein; INR, international normalized ratio; LDL,
low-density lipoprotein; PT, prothrombin time; PTT, partial thromboplastin time; RF, rheumatoid factor.
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The Diagnosis | Pseudohyperbicarbonatemia due to
paraproteinemia
Because of the patient’s benign clinical appearance and a
negative anion gap (13), the possibility of a spurious result
was entertained. An arterial blood gas was sent at the same time
as the chemistry (Table 2), which suggested a falsely elevated
bicarbonate reading. To confirm this finding, the chemistry was
checked immediately (‘stat’) after being drawn, and the
bicarbonate level was similar to the level seen on the blood
gas. This finding is further supported by the subsequent
outpatient laboratory findings: after the patient began treat-
ment for Waldenstrom’s macroglobulinemia with bendamustin
and rituximab, her serum IgM levels returned to the normal
range, and the routine chemistry results also revealed a
bicarbonate level within the normal range (Figure 1).
Paraproteins may cause abnormal laboratory findings
in three ways: (1) through the disease process itself; (2) by
interacting with the target of an assay; and (3) by creating
spurious results because of their interference with the assay
method.1 Paraproteins have been shown to cause interference
with the assays of multiple laboratory tests, including blood
counts, sodium, calcium, phosphorus, lipids, coagulation
profiles, iron studies, blood urea nitrogen, creatinine,
bilirubin, c-reactive protein, glucose, uric acid, lactate
dehydrogenase, and alkaline phosphatase.2,3 Table 3 lists a
summary of interferences documented in the literature.
Among the paraproteins, IgM is more often the culprit
because of its high molecular weight. The above case is the
Table 2 | Comparison of routine results with arterial blood gas
and immediate results
Chemistry Arterial blood gas
Routine Immediate
Sodium 134mmol/l 134mmol/l pH 7.42
Potassium 4.1mmol/l 3.6mmol/l pCO2 37
Chloride 103mmol/l 102mmol/l pO2 157
Carbon dioxide 35mmol/l 22mmol/l HCO3 23
Blood urea nitrogen 10mg/dl 13mg/dl Base excess 0.6
Creatinine 0.39mg/dl 0.47mg/dl Total CO2 24
Oxygen saturation 100%
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Figure 1 | Serum IgM levels compared with serum bicarbonate
levels over time.
Table 3 | Pseudorenal panel abnormalities described with paraproteinemia
Chemical Paraprotein type described Effect Mechanism
Sodium IgG, IgM, IgA Hyponatremia Water exclusion effecta
Chloride IgG Hypochloridemia Water exclusion effect
CO2 IgG, IgM Hypobicarbonatemia Interaction between paraprotein and assay reagent
Blood urea nitrogen IgM Low urea levels Paraprotein coats electrodes and interferes with ionic conductance
Creatinine IgG Low creatinine levels Precipitationb
Creatinine IgM High creatinine levels Interaction between paraprotein and assay reagent
Calcium IgA, IgM Hypercalcemia Precipitation
Phosphate IgG, IgM, IgA Hyperphosphatemia Precipitation in acid pH
Phosphate IgG Hypophosphatemia Precipitation
Albumin IgM Hypoalbuminemia Slowing of reaction
aIncreased colloid phase decreases the aqueous phase per volume of sample resulting in plasma having lower levels of electrolytes per volume of sample.
bImmunoglobulins can precipitate or flocculate because of chemical interaction with the test reagents or to their inherent chemical structure.
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first reported case of an elevated spurious bicarbonate result
secondary to paraproteinemia.
Different types of assays may be affected, including
turbidometry, photometry, nephelometry, and immunologi-
cal assays.4,5 Both false-positive and false-negative results may
occur.5–7 Reports have noted that a single assay method may
reveal incorrect results on a machine from one manufacturer,
but accurate results on a machine made by a different
manufacturer. In general, the paraprotein interference is
concentration dependent. Techniques to avoid spurious
results include alternate assay methods, the use of machines
by different manufacturers, or removal of the paraprotein
load before laboratory analysis. At our laboratory, the CO2-L
using the Roche ammonia/ethanol/CO2 calibrator (Roche
Diagnostics, Indianapolis, IL) is used. It is possible that the
interference might be precipitation related to the IgM protein
and the serum sitting in that milieu for longer time compared
with the emergent sample done.
It is prudent to have a high clinical suspicion of abnormal
laboratory values in the setting of paraproteins, as the
machines are usually unable to detect interference on their
own. We may thus reduce or prevent incorrect diagnoses,
prolonged hospital stays, prescription of inappropriate
treatment, and morbidity or mortality.
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